Similarly, immunofluorescence staining for pCREB demonstrated that treatment of mice with Adrb2 agonist alleviated the inhibition of endothelial CREB phosphorylation in the femoral heads of MPS-treated mice at both 1 week and 6 weeks (Fig. S13f, g). This evidence concerns the gene ADRB2 and mucopolysaccharidosis.